Detalhe da pesquisa
1.
Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G.
Vaccines (Basel)
; 12(3)2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543928
2.
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.
Vaccines (Basel)
; 11(3)2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992257
3.
Combination Ad26.RSV.preF/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models.
NPJ Vaccines
; 8(1): 45, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949051
4.
Immunogenicity and protective efficacy of adenoviral and subunit RSV vaccines based on stabilized prefusion F protein in pre-clinical models.
Vaccine
; 40(6): 934-944, 2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973849
5.
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.
NPJ Vaccines
; 3: 25, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29977611
6.
HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.
Front Immunol
; 7: 399, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746785
7.
A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.
Science
; 349(6254): 1301-6, 2015 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26303961